John Gill, Director at Altimmune, Inc. (ALT), sold 8,425 shares at $11.92 ($100K) on 2020-11-30, disclosed to the SEC on 2020-12-02.
Open-market sale of $100k ALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALT | SELL | 2023-07-06 | $41K | — | Filing → |
| ALT | BUY | 2017-06-06 | $4K | — | Filing → |